Plasma ceramides Plasma ceramides predict the risk of myocardial infarction, coronary revascularization, acute coronary syndrome hospitalization and mortality within 5 years. Ceramide risk score Elevated plasma ceramides are associated with an increased risk of myocardial infarction, acute coronary syndromes, and mortality within 1–5 years. The Score is based on trial data including >4000 subjects. Ceramide score Risk category 0–2 Lower 3–6 Moderate 7–9 Increased 10–12 Higher Risk conferred by plasma ceramides is independent of low-density lipoprotein (LDL) cholesterol, C-reactive protein, LDL particles, and lipoprotein-associated phospholipase A2. Plasma ceramides can be lowered by diet, exercise, simvastatin, rosuvastatin, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors This test measures the levels of ceramides in the blood. All cells make ceramides. They play a big role in the way many types of tissue grow, work and die. Ceramides are linked to atheroscleros
Blog shows articles written by journalist from Karnataka Mr. Manohar Yadavatti on Politics, Nature, People etc